Spain's Patient Support Programs (PSP) market is expected to grow from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of 8.9% for the year 2022-30. Continuous monitoring and assistance required for the management of chronic diseases and the implementation of smarter technologies in Spain are driving the Spain Patient Support Programs (PSP) market. The market is segmented by functionality outlook, therapeutic outlook, application outlook, and the end user. Some of the major PSP operators in the Spain Patient Support Programs (PSP) market include Ashfield Engage, Evidenze, and Clover
Spain's Patient Support Programs (PSP) market is expected to grow from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of 8.9% for the year 2022-30. One of the most popular travel destinations in Europe, Spain is also home to some of the world's top universities. The healthcare system in Spain is considered to be one of the best in the world. It provides universal healthcare across Spain and is mostly funded by social security contributions from taxpaying citizens.
The budget allotted to the Ministry of Health in 2023 will rise by 6.5%, totalling $3322.15 Mn, in the context of a decentralized healthcare system where spending by the Spanish Ministry of Health accounts for less than 3% of overall government spending. This amount reflects the distribution of funding from the national public budget for 2023 as well as the European Recovery and Resilience Facility. Notably, $3.43 Mn and $4.50 Mn are allotted to the newly established National Public Health Agency and the national network for public health surveillance, respectively. A further $1409.29 Mn has been set up for the centralized purchase of the COVID-19 vaccine.
Through promoting treatment adherence, enhancing clinical outcomes, enhancing patient experience, and enhancing the quality of life, patient support programs seek to offer answers that go beyond the medicine itself. Spanish patient support programs are created to give patients access to knowledge, instruction, and services that can help them manage their medical conditions. These initiatives seek to enhance patients' quality of life while guiding them through Spain's intricate healthcare system. To assist patients in understanding their diseases and available treatments, many patient support organizations in Spain offer educational materials. Some examples of patient support programs in Spain include AEAL (Spanish Association of Patients with Lymphoma, Myeloma, and Leukemia), FEDER (Spanish Federation of Rare Diseases), and ACCU Spain (Spanish Association of Crohn's and Ulcerative Colitis).
Market Growth Drivers
In Spain, chronic conditions like diabetes, heart disease, and cancer are becoming more common. PSP can offer the continuing monitoring and assistance that these diseases demand. The need for PSP is anticipated to increase as the population ages. Delivering PSP to patients has become simpler due to technological developments like telemedicine and smartphone applications. This could boost PSP effectiveness and patient involvement, both of which could contribute to the Spain PSP market expansion.
Significant time, money, and human capital are needed for PSP implementation and administration. The expansion of the Spain PSP market can be limited by the lack of resources for investment in PSP by small and mid-sized pharmaceutical businesses. In order to adopt PSP, patient data privacy is a crucial problem, and businesses must adhere to the General Data Protection Regulation (GDPR). Concerns regarding data privacy may prevent some patients from taking part in PSP.
Major Patient Support Programs in Spain
|Patient Support Programs||Focus Area||Pharma Sponsor|
|KabiCare||Autoimmune diseases||Fresenius Kabi|
|Abbvie Care||Parkinson, Immunology, Neonatology, and soon starting with Oncology||Abbvie|
|Connect 360||AstraZeneca therapies||AstraZeneca|
|Atopic KIDS||Atopic dermatitis||Sanofi|
|Parkinson's Well-Being Map||Parkinson||UCB|
|Ayuda Múltiple||Relapsing MS||Teva|
|Humanitarian Program for Rare Diseases||Rare disease (lysosomal storage disorders)||Sanofi|
|MultiplicArte 2022||Multiple sclerosis (MS)||Bristol Myers Squibb|
|Spanish association of people affected with lung cancer||Lung Cancer||Takeda|
|Sharing Health 2.0||Pompe- Rare Disease||Sanofi|
|Em One to One||Multiple Sclerosis (MS)||Sanofi|
|Sanofi with diabetes||Diabetes Mellitus||Sanofi|
Patient support programs were mentioned in Royal Decree 957/2020, of 3 November, on the regulation of non-interventional studies of medicinal products for human use. Despite the rise of patient support programs ("PSPs") in recent years, up-to-date regulation on such programs has been relatively scarce.
According to RD 957/2020, it is forbidden to run or sponsor observational studies (OS) with the objective to promote medicines. Then it adds that PSPs under which information is gathered through “planned contacts with patients” can only be carried out in Spain under a protocol that contemplates any of the purposes identified in the definition of observational studies. According to Catalonian guidelines on PSP, the programs must serve to help the patients understand the development of the disease, improve their quality of life or contribute to adequate compliance with the treatment. In Spain, only health care professionals (HCPs) or patient organizations are allowed to communicate PSPs to patients.
1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
188.8.131.52 Product Applications and Services
184.108.40.206 Recent Developments
220.127.116.11 Partnerships Ecosystem
18.104.22.168 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Functionality Outlook
By Therapeutic area outlook
By Application outlook
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses